PK and Safety in Participants Taking Obicetrapib With Moderate Hepatic Impairment Relative to Normal Hepatic Function

Phase 1 Study of Multiple-Dose Pharmacokinetics of Cenicriviroc in Subjects With Mild and Moderate Hepatic Impairment

NCT02120547 ·Status: COMPLETED ·Phase: PHASE1

A Research Study on Etavopivat in Participants With and Without Liver Disease

NCT06336018 ·Status: COMPLETED ·Phase: PHASE1

Hepatic Impairment Study

NCT00829231 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Effect of Moderate or Severe Hepatic Impairment on the Pharmacokinetics (PK) of Inavolisib

NCT07144111 ·Status: RECRUITING ·Phase: PHASE1

A Study to Evaluate the Pharmacokinetics of Divarasib in Healthy Participants and Participants With Impaired Hepatic Function

NCT06734208 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetic Study of Alpelisib in Subjects With Hepatic Impairment.

NCT02624557 ·Status: COMPLETED ·Phase: PHASE1

Investigating the Effect of Food on the Bioavailability of a Fixed Dose Combination of Obicetrapib and Ezetimibe

NCT06050291 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Effect of SCY-078 on the PK of Dabigatran in Healthy Subjects

NCT04092725 ·Status: COMPLETED ·Phase: PHASE1

Study to Assess the Pharmacokinetics of Cabozantinib (XL184) in Hepatic Impaired Adult Subjects

NCT01493869 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics of KBP-5074 in Patients With Moderate Hepatic Impairment

NCT04534699 ·Status: COMPLETED ·Phase: PHASE1

Nintedanib in Volunteers With Hepatic Impairment Compared With Healthy Volunteers

NCT02191865 ·Status: COMPLETED ·Phase: PHASE1

A Study to Test How BI 1584862 is Taken up in the Blood of People With and Without Liver Problems

NCT06957756 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Study Examining The Effect Of Hepatic Impairment On Safety, Toleration And How The Body Processes An Experimental Drug

NCT00645021 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Pharmacokinetics of CC-90001 in Subjects With Mild, Moderate, and Severe Hepatic Impairment Compared With Healthy Subjects

NCT03742882 ·Status: COMPLETED ·Phase: PHASE1

A Study to Test How Different Doses of BI 685509 Are Tolerated in Patients With Liver Problems

NCT03842761 ·Status: COMPLETED ·Phase: PHASE1

A Pharmacokinetic Study of Baricitinib in Participants With Liver Disease

NCT01870388 ·Status: COMPLETED ·Phase: PHASE1

Influence of Different Degrees of Renal Impairment on the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of BIBT 986 BS in Subjects With Normal Renal Function and Patients With Different Degrees of Renal Impairment

NCT02254070 ·Status: COMPLETED ·Phase: PHASE1

Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics of CTP-543

NCT05467722 ·Status: COMPLETED ·Phase: PHASE1

A Study of Calderasib (MK-1084) in Participants With Hepatic Impairment and Healthy Volunteers (MK-1084-017)

NCT07219550 ·Status: RECRUITING ·Phase: PHASE1

Pharmacokinetics of Fevipiprant (QAW039) in Patients With Hepatic Impairment Compared to Matched Healthy Subjects

NCT03048448 ·Status: COMPLETED ·Phase: PHASE1

Safety and Pharmacokinetics of Zanubrutinib (BGB-3111) in Healthy Subjects and Those With Impaired Liver Function

NCT03465059 ·Status: COMPLETED ·Phase: PHASE1

Relative Bioavailability of 1 mg and 10 mg BI 1356 BS as Powder in the Bottle (PIB) to 1 mg and 10 mg BI 1356 BS as Tablets as Single Oral Administration in Healthy Male Volunteers Including the Influence of Food on the Bioavailability of 10 mg BI 1356 BS

NCT02180503 ·Status: COMPLETED ·Phase: PHASE1

Phase I, Open Label,Crossover Food-Effect and Absolute Bioavailability Study of WCK2349 and WCK771 in Healthy Adult Human Volunteers

NCT01875939 ·Status: COMPLETED ·Phase: PHASE1

Single-Dose PK and Safety Study of GBT440 in Subjects With Hepatic Impairment

NCT03114540 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics and Pharmacodynamics of BI 1356 in Subjects With Different Degrees of Liver Impairment as Compared to Healthy Subjects

NCT02183376 ·Status: COMPLETED ·Phase: PHASE1